| Product Code: ETC7537127 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Asthma and COPD Drug Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Asthma and COPD Drug Market Revenues & Volume, 2021 & 2031F |
3.3 India Asthma and COPD Drug Market - Industry Life Cycle |
3.4 India Asthma and COPD Drug Market - Porter's Five Forces |
3.5 India Asthma and COPD Drug Market Revenues & Volume Share, By Diseses, 2021 & 2031F |
3.6 India Asthma and COPD Drug Market Revenues & Volume Share, By Medication Class, 2021 & 2031F |
4 India Asthma and COPD Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of asthma and COPD in India |
4.2.2 Rising awareness about respiratory diseases and treatment options |
4.2.3 Growing healthcare infrastructure and access to medical facilities in India |
4.3 Market Restraints |
4.3.1 High cost associated with asthma and COPD medications |
4.3.2 Lack of proper diagnosis and treatment facilities in rural areas |
4.3.3 Limited reimbursement policies for asthma and COPD drugs in India |
5 India Asthma and COPD Drug Market Trends |
6 India Asthma and COPD Drug Market, By Types |
6.1 India Asthma and COPD Drug Market, By Diseses |
6.1.1 Overview and Analysis |
6.1.2 India Asthma and COPD Drug Market Revenues & Volume, By Diseses, 2021- 2031F |
6.1.3 India Asthma and COPD Drug Market Revenues & Volume, By Asthma, 2021- 2031F |
6.1.4 India Asthma and COPD Drug Market Revenues & Volume, By COPD, 2021- 2031F |
6.2 India Asthma and COPD Drug Market, By Medication Class |
6.2.1 Overview and Analysis |
6.2.2 India Asthma and COPD Drug Market Revenues & Volume, By Combination Drugs, 2021- 2031F |
6.2.3 India Asthma and COPD Drug Market Revenues & Volume, By Short Acting Beta Agonists (SABA), 2021- 2031F |
6.2.4 India Asthma and COPD Drug Market Revenues & Volume, By Long Acting Beta Agonists (LABA), 2021- 2031F |
6.2.5 India Asthma and COPD Drug Market Revenues & Volume, By Leukotriene Antagonists (LTA), 2021- 2031F |
6.2.6 India Asthma and COPD Drug Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.2.7 India Asthma and COPD Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 India Asthma and COPD Drug Market Import-Export Trade Statistics |
7.1 India Asthma and COPD Drug Market Export to Major Countries |
7.2 India Asthma and COPD Drug Market Imports from Major Countries |
8 India Asthma and COPD Drug Market Key Performance Indicators |
8.1 Number of patients diagnosed with asthma and COPD annually |
8.2 Percentage of population using inhalers or other respiratory medications |
8.3 Rate of adoption of new and advanced treatment options for asthma and COPD |
9 India Asthma and COPD Drug Market - Opportunity Assessment |
9.1 India Asthma and COPD Drug Market Opportunity Assessment, By Diseses, 2021 & 2031F |
9.2 India Asthma and COPD Drug Market Opportunity Assessment, By Medication Class, 2021 & 2031F |
10 India Asthma and COPD Drug Market - Competitive Landscape |
10.1 India Asthma and COPD Drug Market Revenue Share, By Companies, 2024 |
10.2 India Asthma and COPD Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here